Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis
K. M. Pantalone, M. W. Kattan, C. Yu, B. J. Wells, S. Arrigain, A. Jain, A. Atreja, R. S. ZimmermanVolume:
14
Year:
2012
Language:
english
Pages:
1
DOI:
10.1111/j.1463-1326.2012.01604.x
File:
PDF, 532 KB
english, 2012